Temsirolimus Kit
Product Images NDC 65219-200

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 65219-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tem07 0001 01)

Chemical structure of temsirolimus, an active ingredient. The diagram displays the molecular arrangement including rings, bonds, and functional groups characteristic of temsirolimus.*

FDA Label Image

Figure (Tem07 0001 02)

A survival distribution function graph comparing months to death from randomization between two treatments: Interferon and Temsirolimus injection at 25 mg/week. The graph shows survival probabilities over a 30-month period, with Temsirolimus indicated by a solid line and Interferon by a dashed line.*

FDA Label Image

Fresenius Kabi Logo (Tem07 0001 03)

FDA Label Image

Principal Display Panel – 25 mg/ml Per Vial* (Carton)

Temsirolimus Injection 25 mg/mL per vial kit packaging label. The label indicates a single-dose vial with 0.2 mL overfill. It is for intravenous infusion only, concentrated requiring two dilutions before administration, resulting in 10 mg/mL after initial dilution. The label includes storage instructions to refrigerate and information about contents and diluent. Manufactured for Fresenius Kabi USA, LLC.*

FDA Label Image

Principal Display Panel – 25 mg/ml Per Vial* (Vial Label)

Label for Temsirolimus Injection 25 mg/mL single-dose vial, refrigerated. Contains dehydrated alcohol 49.90% v/v. Includes dilution instructions with reference to an insert. Manufactured by Fresenius Kabi Lake Zurich, IL, made in India. The label shows NDC 65219-205-05 and a barcode, with placeholders for lot number and expiration date.*

FDA Label Image

Principal Display Panel – 2.2 mL (Vial Label)

Label for Temsirolimus Diluent for Injection kit, NDC 65219-202-05, by Fresenius Kabi USA, LLC. The label states it is not for direct administration and intended only for dilution of temsirolimus injection vial. It contains 2.2 mL, includes dehydrated alcohol 25.14% v/v, and is a single dose vial. Storage instructions specify refrigeration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.